Post-effective amendment to a registration statement that is not immediately effective upon filing

Reverse Recapitalization - Consummation of the merger (Details)

v3.22.1
Reverse Recapitalization - Consummation of the merger (Details) - shares
12 Months Ended
May 24, 2021
Dec. 31, 2021
Dec. 31, 2020
Business Acquisition [Line Items]      
Total shares of common stock immediately after Merger   58,510,550 42,973,462
Merger agreement      
Business Acquisition [Line Items]      
Common stock, outstanding prior to Merger   552,412  
Less: redemption of BRPA shares   (216)  
Common stock of BRPA   552,196  
Shares issued in PIPE Financing   1,000,000  
Shares issued for services   200,000  
Shares issued pursuant to conversion of Public and Private Rights   717,250  
Merger and PIPE Financing shares - common stock   3,729,730  
Total shares of common stock immediately after Merger   48,603,585  
Merger agreement | Stockholders of NeuroRx      
Business Acquisition [Line Items]      
BRPA Founder and private shares, net of forfeited shares of 875,216 50,000,000    
NeuroRx shares - common stock (1)   44,873,855  
Common stock outstanding upon conversion prior to Merger   14,200,586  
Merger agreement | BRPA Founder and private shares      
Business Acquisition [Line Items]      
BRPA Founder and private shares, net of forfeited shares of 875,216   1,260,284  
Number of shares forfeited   875,216